NuGen Medical Devices Inc.
NGMDF
$0.068
$0.022549.45%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 560.00K | 256.40K | 262.30K | 245.10K | 137.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 560.00K | 256.40K | 262.30K | 245.10K | 137.30K |
| Cost of Revenue | 296.60K | 130.10K | 133.20K | 122.90K | 56.80K |
| Gross Profit | 263.20K | 126.20K | 128.90K | 122.10K | 80.50K |
| SG&A Expenses | 4.56M | 4.41M | 5.45M | 5.57M | 4.85M |
| Depreciation & Amortization | 470.80K | 489.90K | 506.10K | 512.10K | 575.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.33M | 5.03M | 6.09M | 6.21M | 5.48M |
| Operating Income | -4.77M | -4.77M | -5.83M | -5.96M | -5.34M |
| Income Before Tax | -6.08M | -5.62M | -6.71M | -6.91M | -6.32M |
| Income Tax Expenses | 26.60K | 19.20K | 24.90K | 24.90K | 7.10K |
| Earnings from Continuing Operations | -6.11 | -5.64 | -6.73 | -6.94 | -6.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.11M | -5.64M | -6.73M | -6.94M | -6.33M |
| EBIT | -4.77M | -4.77M | -5.83M | -5.96M | -5.34M |
| EBITDA | -4.31M | -4.29M | -5.31M | -5.45M | -4.86M |
| EPS Basic | -0.03 | -0.03 | -0.04 | -0.04 | -0.05 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 |
| EPS Diluted | -0.03 | -0.03 | -0.04 | -0.04 | -0.05 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 |
| Average Basic Shares Outstanding | 837.30M | 804.58M | 752.84M | 669.97M | 557.03M |
| Average Diluted Shares Outstanding | 837.30M | 804.58M | 752.84M | 669.97M | 557.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |